vedolizumab,infliximab
janssen,takeda
[' vedo', 'ibd', 'infliximab', 'vedo', 'vedolizumab']
zhigang liu presents data from on neutralising ab potency against sars-cov-2 wild type and omicron variants in pts w/ #ibd treated w/ infliximab or vedolizumab after 3 doses of sars-cov-2 vaccine; more here: #gitwitter #ecco2023 #ecco23 
The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=45.042. #Lancet200